Tate & Lyle PLC (TATE) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Tate & Lyle PLC stock £3.42, price £5.61, that is 39.0% below the price, quality 44 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range £3.22 – £7.49 · fair‑value band £2.13 – £5.80 · the £5.61 price screens above the £3.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Follow Tate & Lyle in your weekly email
Every Wednesday you see whether Tate & Lyle is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe.
Show moreShow less
Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours.
The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications.
The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Stock analysis
Tate & Lyle PLC (TATE) currently trades at £5.61, while our model-based Fair Value estimate is £3.42, 39% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of £5.55 per share, and 5 of the 24 models we run sit above the £5.61 price.
Bear case: the Asset-Based group reads lowest at £1.22, and 19 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: £2.13 (bear) to £5.80 (bull), the price of £5.61 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Tate & Lyle PLC reported revenue of £2.0B in FY2026 versus £1.4B in FY2022, a compound +9.9%/yr. Reported net income was £97.0M in FY2026, compounding −19.9%/yr from FY2022.
Key figures
Market cap £2.5B Mid · P/E ratio 35.1 · P/S ratio 1.24 · EPS (TTM) £0.1600 · Dividend yield 3.6% · Net margin 3.4% · Return on equity 4.4% · Return on assets (EBIT) 5.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.
The share trades about 1% below its 52-week high and 74% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 3% fair-value upside, at −39%, TATE screens richer than that median.
Fair Value models
Bear£2.13Fair Value £3.42Bull£5.80
Price £5.61 · Downside -39.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.69/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.6%
Start year 2021 (pandemic). Over 10 years: −1.6% a year
Revenue growth 41 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +15.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +11.8%
Dividend (yield on the price)3.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−18.6% vs −6.1%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 11%
⚠ Revenue per share shrinking 3.3%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2021 (starting value 0.29 per share, median 0.68 in 2016 to 2019). It measures the recovery from the trough, not lasting growth.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+13.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +11.1% a year for the price and +0.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (15 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Moderate overall moat stems from the botanical synthesis platform enabling sustainable next-generation sweeteners, yet limited signals of durable advantage leave returns metrics subdued.
Main risk: Limited public signals of durable advantage leave the business exposed to persistently low returns on equity and assets that weaken overall profitability.
Tate & Lyle and BioHarvest have shown that the Botanical Synthesis platform can produce the targeted next-generation sweetening solution. This step supports more sustainable ways to develop ingredients that help food and drink makers cut sugar while improving consistency and resource use. Our models currently see the stock as overvalued. Does the milestone strengthen the case for continued independence or mainly reinforce the logic of the Ingredion deal?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 661 stocks
Beats the industry median on 3/15 measures
Overall it trails its industry peers.
Valuation
Quality Score44 · Bottom 25%
Fair Value upside−39.0% · Bottom 25%
Profitability
Return on equity (12 months)4.4% · Below median
Return on assets2.7% · Below median
Net margin (12 months)3.4% · Below median
Operating margin (12 months)11.6% · Above median
Growth and dividend
Revenue growth (quarter YoY)1.5% · Below median
Dividend yield (12 months)3.6% · Above median
Balance sheet
Debt / equity0.77× · Highest 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (12 months)35.1× · Priciest 25%
P/B1.57× · Pricier than median
P/S (12 months)1.24× · Pricier than median
Price / free cash flow (fiscal year)20.6× · Pricier than median
EV/EBITDA8.7× · Pricier than median
PEG0.59× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 34
FUTURE (revenue growth)8· sector 25
PAST (return on equity)18· sector 30
HEALTH (low debt)62· sector 96
DIVIDEND (yield)71· sector 55
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Tate & Lyle PLC (TATE) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of £3.42 versus a price of £5.61, about 39% lower (overvalued).
What is the fair value of TATE?
Our model-based fair value for Tate & Lyle PLC is £3.42 (as of Nov 12, 2026), built from audited fundamentals. The current price: £5.61.
What is the quality score of TATE?
Tate & Lyle PLC has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Tate & Lyle PLC (TATE)?
Our model-based price target is the fair value of £3.42 (as of Nov 12, 2026) from 24 valuation models. Cautious scenario £2.13, optimistic scenario £5.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Tate & Lyle PLC stock forecast for 2026?
Our models put fair value at £3.42, about 39% lower versus a price of £5.61 (overvalued). Cautious scenario £2.13, optimistic scenario £5.80. The calculation is refreshed regularly with new filings.
What is the revenue of Tate & Lyle PLC (TATE)?
Tate & Lyle PLC reported trailing-twelve-month revenue of about £2.0B (latest available figure, as of Nov 12, 2026).
Does Tate & Lyle PLC pay a dividend?
Tate & Lyle PLC currently shows a dividend yield of 3.57% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Tate & Lyle PLC (TATE) and when is the ex-dividend date?
Tate & Lyle PLC pays a dividend of £0.2 per share a year, a dividend yield of 3.6%. The next ex-dividend date is Nov 19, 2026. A dividend has been paid every year since at least 1992. The payout ratio is 125% of earnings. Free cash flow covers the dividend 1.38 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Tate & Lyle PLC (TATE)?
For today's price to be fair in a discounted-cash-flow model, Tate & Lyle PLC would have to grow free cash flow by +13.7 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.6 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of TATE use?
Our models discount Tate & Lyle PLC at 9.0 %: a base by market capitalisation (mid), damped by beta 0.34, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Tate & Lyle PLC that is +13.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Tate & Lyle PLC (TATE) delivered so far?
Over the past 5 years revenue at Tate & Lyle PLC grew +10.6 % a year. The price currently implies free-cash-flow growth of +13.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Tate & Lyle PLC (TATE) growing?
The median revenue growth in the sector is +3.6 % a year. That is the yardstick for the growth priced into Tate & Lyle PLC (+13.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Tate & Lyle PLC (TATE)?
The free-cash-flow yield on the price is 4.86 %: that much free cash flow Tate & Lyle PLC produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Tate & Lyle PLC (TATE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Tate & Lyle PLC it is £3.42 per share (as of Nov 12, 2026), against a price of £5.61. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Tate & Lyle PLC stock overvalued or undervalued in 2026?
As of Nov 12, 2026, TATE trades above its calculated fair value: price £5.61, fair value £3.42, a gap of about −39% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TATE?
No. The price is what the market pays today (£5.61); the fair value is what the company's own numbers justify (£3.42). For Tate & Lyle PLC the two are £2.19 per share apart. That gap is exactly why we show both numbers side by side.
How much is Tate & Lyle PLC worth?
The market values Tate & Lyle PLC at about £2.5B (market capitalisation, as of Nov 12, 2026). Per share that is £5.61; our models calculate a fair value of £3.42 per share.
What do the bullish and bearish scenarios say about TATE?
Our models span a range for Tate & Lyle PLC: cautious scenario £2.13, base £3.42, optimistic £5.80 per share (as of Nov 12, 2026, price £5.61). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TATE?
Tate & Lyle PLC trades at a price-to-earnings ratio of 35.1 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £3.42 is built from several models across several years. Other multiples: PEG 0.6, P/B 1.6, P/S 1.2, EV/EBITDA 8.7.
What is the PEG ratio of TATE?
The PEG ratio of Tate & Lyle PLC is 0.59 (P/E divided by earnings growth, as of Nov 12, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Tate & Lyle PLC (TATE)?
Balance-sheet figures for Tate & Lyle PLC (as of Nov 12, 2026): return on equity 4.4%, debt of 0.77 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is TATE from its 52-week high?
Tate & Lyle PLC trades at £5.61, about 1% below its 52-week high of £5.66 and 74% above the low of £3.22 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of £3.42 is for.
Which stocks are comparable to Tate & Lyle PLC?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Tate & Lyle PLC stock attractive at the current price?
The data as of Nov 12, 2026: price £5.61, calculated fair value £3.42 (−39%), Quality Score 44/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TATE calculated?
We run Tate & Lyle PLC through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of £3.42 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9% above its aggregate fair value. Tate & Lyle PLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Tate & Lyle PLC (TATE)?
The closing price on Nov 13, 2026 was £5.61. Our model-based fair value is £3.42, about 39% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Tate & Lyle PLC right now?
Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (£2.13 to £5.80). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Where does the earnings growth of Tate & Lyle PLC (TATE) come from?
Earnings per share at Tate & Lyle PLC grew −1.1 % a year from 2015 to 2026. Broken into its drivers: revenue per share −4.1 %, EBIT margin +2.2 %, tax rate −2.7 %, residual (interest, one-offs) +3.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Tate & Lyle PLC
How large is the market capitalisation of Tate & Lyle PLC (TATE)?
The market capitalisation of Tate & Lyle PLC is £2.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Tate & Lyle PLC (TATE)?
The price-to-sales ratio of Tate & Lyle PLC is 1.24 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Tate & Lyle PLC (TATE)?
Earnings per share at Tate & Lyle PLC are £0.1600 (price ÷ EPS = P/E 35.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Tate & Lyle PLC (TATE)?
The dividend yield of Tate & Lyle PLC is 3.6% (payout 125%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Tate & Lyle PLC (TATE)?
The net margin of Tate & Lyle PLC is 3.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Tate & Lyle PLC (TATE)?
The return on equity (ROE) of Tate & Lyle PLC is 4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Tate & Lyle PLC (TATE)?
On an EBIT basis the return on assets of Tate & Lyle PLC is 5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Tate & Lyle PLC (TATE)?
The operating margin of Tate & Lyle PLC is 11.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Tate & Lyle PLC (TATE)?
Revenue at Tate & Lyle PLC is growing +1.5% versus a year earlier (3y avg +4.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Tate & Lyle PLC (TATE)?
Earnings per share at Tate & Lyle PLC are growing −49.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Tate & Lyle PLC (TATE) carry?
The net debt of Tate & Lyle PLC is £950M (fiscal year 2026, ≈ 7.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Tate & Lyle PLC in the live analysis
One click puts Tate & Lyle PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 12, 2026